Atlas Enterprise, one of many main enterprise capital corporations within the biotech business, has raised $450 million for a brand new fund, the agency’s leaders informed STAT solely.
The fund — Atlas’ 14th — will go in direction of seed and collection A rounds for biotech corporations, most of which the agency may have a hand in creating. Atlas hardly ever takes exterior pitches from entrepreneurs, although it should generally group up with different VC corporations which have launched a brand new startup.
The information comes just some weeks after Associate Bruce Sales space talked about that the agency was elevating the fund throughout his annual “year-in-review” video presentation.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
